Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Discover how ctDNA revolutionizes multiple myeloma monitoring, tracking disease progression, and improving personalized ...

Multiple Genetic Abnormalities Lead to Poor Prognosis Around 5900 people are diagnosed with myeloma each year in the UK. Standard treatments include targeted drugs, chemotherapy, and stem cell ...

Genetic testing should be used to help doctors ... in better understanding and defining the needs of high-risk multiple myeloma patients. "Every cancer patient should have the opportunity for ...

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

A new study from researchers at the University of Leipzig Medical Center and collaborators, has discovered a rare but serious ...

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

Instead, multiple myeloma develops due to genetic mutations (changes) in the DNA of plasma cells. What causes these genetic mutations is not fully understood, but a combination of environmental ...

Blood tests used to stage multiple myeloma include: Cytogenetics is a way of looking for genetic abnormalities in cells. Cytogenetic tests use blood, tissue, or bone marrow samples to look for ...